Payer Almanac
About the data Sign in
Star measuresDisplay measuresHEDISWhy members leave

Measures · D12 in 2026 · Part D · DD4 Drug Safety and Accuracy of Drug Pricing

Statin Use in Persons with Diabetes (SUPD)

Drug PlanMedication AdherenceSource: Prescription Drug Events

What it measures
To lower their risk of developing heart disease, most people with diabetes should take cholesterol medication. This rating is based on the percent of plan members with diabetes who take the most effective cholesterol-lowering drugs. Plans can help make sure their members get these prescriptions filled.
How it's calculated
This measure is defined as the percentage of Medicare Part D beneficiaries, 40-75 years old, who were dispensed at least two diabetes medication fills on unique dates of service and received a statin medication fill during the measurement period. The index prescription start date (IPSD) is the earliest date of service for a diabetes medication during the measurement year. Continuous enrollment (CE) is defined as being continuously enrolled in a Medicare Part D contract during the measurement period, with one allowable gap in enrollment of up to one calendar month. Beneficiaries are only included in the measure calculation if the IPSD occurs at least 90 days before the end of the measurement period. The percentage is calculated as the number of continuously enrolled beneficiaries, 40- 75 years old, who received a statin medication fill during the measurement period (numerator) divided by the number of continuously enrolled beneficiaries, 40-75 years old, with at least two diabetes medication fills on unique dates of service during the measurement period and an IPSD that occurs at least 90 days prior to the end of the measurement period (denominator). The SUPD measure is adapted from the measure concept that was developed and endorsed by the PQA. See the medication list for this measure. The SUPD measure is calculated using the NDC lists updated by the PQA. The complete NDC lists, including diagnosis codes, are posted along with these technical notes.
Data source
Prescription Drug Event (PDE) data The data for this measure come from Prescription Drug Event (PDE) data submitted by drug plans to the CMS DDPS and accepted by the 2024 PDE submission deadline for annual Part D payment reconciliation with dates of service from January 1, 2024 – December 31, 2024. If the PDE edit results in the PDE being rejected by DDPS, then the PDE is not used in the Patient Safety measure calculations. If the PDE edit is informational and therefore does not result in the PDE being rejected, then the PDE is used in the Patient Safety measure calculations. Reminder, CMS uses the term “final action” PDE to describe the most recently accepted original, adjustment, or deleted PDE record representing a single dispensing event. Original and adjustment final action PDEs submitted by the sponsor and accepted by DDPS prior to the 2024 PDE submission deadline are used to calculate this measure. PDE adjustments made post- reconciliation were not reflected in this measure. Additional data sources include the CME, the CWF, and the EDS. The data cutoff date for all the additional data sources listed below such as the CME, CWF, and EDS is determined by the same PDE submission deadline for the annual Part D payment reconciliation. • CME is used for enrollment information and to identify beneficiaries who elected to receive hospice care or with ESRD status (dialysis start and end dates within the measurement period). • CWF is used to identify exclusion diagnoses based on ICD-10-CM codes. • EDS is used to identify exclusion diagnoses based on ICD-10-CM codes.
Measurement period
01/01/2024 – 12/31/2024
Better when
Higher
Weight
1 (Process Measure)
Star assignment
Clustering
Case-mix adjusted
No
In improvement measure
Yes
Used in CAI
Yes
Exclusions
ShowContracts with 30 or fewer continuously enrolled beneficiaries (in the denominator). The following beneficiaries are excluded from the denominator if at any time during the measurement period: • Hospice enrollment • ESRD diagnosis or dialysis coverage dates • Rhabdomyolysis and Myopathy • Pregnancy, Lactation, and Fertility • Cirrhosis • Pre-Diabetes • Polycystic Ovary Syndrome
Notes
Part D drugs do not include drugs or classes of drugs, or their medical uses, which may be excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, except for smoking cessation agents. As such, these drugs, which may be included in the PQA medication or NDC lists, are excluded from CMS analyses.
Disaster policy
Higher measure star (2025-2026) for contracts with 25% or more enrolled affected by 2024 disasters. Meaningful Measure Chronic Conditions Area:

From the 2026 Star Ratings Technical Notes (CMS).

Cut points over time

Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.

How the 2028 cut points are projected

Each boundary moves by its median year-on-year change since 2019, capped at 5 points, the most CMS lets a non-survey cut point move in a year. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.

StarsOrg type2027Projected 2028Move
2★MA-PD8384.5+1.5
3★MA-PD8789+2
4★MA-PD9091+1
5★MA-PD9495+1
2★PDP8182.5+1.5
3★PDP8383.5+0.5
4★PDP8585.5+0.5
5★PDP8788+1

2026 star distribution

Not rated: Plan too new to be measured (93); Not enough data available (61); Plan not required to report measure (8)

Cut point bands

Star yearOrg type1★2★3★4★5★
2027MA-PD< 83 %>= 83 % to < 87 %>= 87 % to < 90 %>= 90 % to < 94 %>= 94 %
2027PDP< 81 %>= 81 % to < 83 %>= 83 % to < 85 %>= 85 % to < 87 %>= 87 %
2026MA-PD< 81 %>= 81 % to < 85 %>= 85 % to < 89 %>= 89 % to < 93 %>= 93 %
2026PDP< 82 %>= 82 % to < 83 %>= 83 % to < 84 %>= 84 % to < 86 %>= 86 %
2025MA-PD< 81 %>= 81 % to < 86 %>= 86 % to < 89 %>= 89 % to < 93 %>= 93 %
2025PDP< 80 %>= 80 % to < 83 %>= 83 % to < 85 %>= 85 % to < 87 %>= 87 %
2024MA-PD< 81 %>= 81 % to < 86 %>= 86 % to < 88 %>= 88 % to < 92 %>= 92 %
2024PDP< 81 %>= 81 % to < 83 %>= 83 % to < 85 %>= 85 % to < 87 %>= 87 %
2023MA-PD< 80 %>= 80 % to < 84 %>= 84 % to < 86 %>= 86 % to < 90 %>= 90 %
2023PDP< 80 %>= 80 % to < 82 %>= 82 % to < 84 %>= 84 % to < 86 %>= 86 %
2022MA-PD< 76 %>= 76 % to < 80 %>= 80 % to < 84 %>= 84 % to < 88 %>= 88 %
2022PDP< 77 %>= 77 % to < 79 %>= 79 % to < 82 %>= 82 % to < 84 %>= 84 %
2021MA-PD< 77 %>= 77 % to < 81 %>= 81 % to < 83 %>= 83 % to < 87 %>= 87 %
2021PDP< 74 %>= 74 % to < 79 %>= 79 % to < 82 %>= 82 % to < 85 %>= 85 %
2020MA-PD< 74%? 74% to < 78%? 78% to < 81%? 81% to < 83%? 83%
2020PDP< 76%? 76% to < 78%? 78% to < 79%? 79% to < 83%? 83%
2019MA-PD< 72%? 72% to < 76%? 76% to < 80%? 80% to < 83%? 83%
2019PDP< 73%? 73% to < 77%? 77% to < 79%? 79% to < 82%? 82%

Lowest-scoring contracts, 2026

ContractParentMembersScoreStarsΔShortfall to 4★Pctile
H1526 Gold Kidney Health PlanGold Kidney Health Plan3,058701—190%
S5795 Arkansas Blue MedicareUSAble Mutual Insurance Company19,195791050%
H7779 American Health Advantage of TennesseeMitchell Family Office2977210170%
H6743 ATRIO Health PlansATRIO Health Plans21,0427710120%
H3810 AllCare AdvantageAllCare Health, Inc.2,4857710120%
H2926 PrimeWest HealthPrimeWest Rural MN Health Care Access Initiative7497710120%
H9489 Vermont Blue AdvantageBlue Cross Blue Shield of Michigan Mutual Ins. Co.07710120%
H8947 Peak HealthWest Virginia United Health System, Inc.12,866771—120%
H1347 Patrius HealthBlueCross BlueShield of Alabama4,544781—111%
H1350 Blue Cross of IdahoGemstone Holdings, Inc.32,4067810111%
H4232 American Health Advantage of UtahMitchell Family Office2967810111%
H6202 NextBlue of North DakotaBlue Cross Blue Shield of Michigan Mutual Ins. Co.6,7097910102%
H1304 Regence BlueShield of IdahoCambia Health Solutions, Inc.9027910102%
H4213 Arkansas Blue MedicareUSAble Mutual Insurance Company2,2587910102%
H3251 Blue Cross and Blue Shield of New MexicoHealth Care Service Corporation19,880791−1102%
H5435 UnitedHealthcareUnitedHealth Group, Inc.1,420791−1102%
H3814 ATRIO Health PlansATRIO Health Plans1,9977910102%
H8095 Wellmark Advantage Health PlanBlue Cross Blue Shield of Michigan Mutual Ins. Co.0791−1102%
R6694 Aetna MedicareCVS Health Corporation899791−1102%
H6851 WellSense Health PlanBMC Health System, Inc.4,2267910102%
H9699 Arkansas Blue MedicareUSAble Mutual Insurance Company7,909791−1102%
H6379 Clear Spring HealthGroup 1001—791—102%
S5726 Blue Cross and Blue Shield of KansasBlue Cross Blue Shield of Kansas153,378801−143%
S1030 BlueRx (PDP)BlueCross BlueShield of Alabama30,843801−143%
H9042 MyTruAdvantageSIHO Holding, Inc.8,659801−194%

History

Star yearCodeNameMeasuredWeightSource
2027D11Statin Use in Persons with Diabetes (SUPD)01/01/2025 – 12/31/20251Prescription Drug Events
2026D12Statin Use in Persons with Diabetes (SUPD)01/01/2024 – 12/31/20241Prescription Drug Events
2025D12Statin Use in Persons with Diabetes (SUPD)01/01/2023 – 12/31/20231Prescription Drug Events
2024D12Statin Use in Persons with Diabetes (SUPD)01/01/2022 – 12/31/20221Prescription Drug Events
2023D12Statin Use in Persons with Diabetes (SUPD)01/01/2021 – 12/31/20211Prescription Drug Events
2022D12Statin Use in Persons with Diabetes (SUPD)01/01/2020 – 12/31/20203Prescription Drug Events
2021D14Statin Use in Persons with Diabetes (SUPD)01/01/2019 – 12/31/20193Prescription Drug Events
2020D14Statin Use in Persons with Diabetes (SUPD)01/01/2018 – 12/31/20181Prescription Drug Events
2019D14Statin Use in Persons with Diabetes (SUPD)01/01/2017 – 12/31/20171Prescription Drug Events